VOLT-02
VOLT-02 is a water-soluble conjugate of progesterone and a neurosteroid which is under development by Levolta Pharmaceuticals (formerly Voltarra Pharmaceuticals) for the treatment of traumatic brain injury, gynecological disorders, and menstrual disorders.[1] As of March 2017, it is in phase II clinical trials for these indications.[1] The chemical structure of VOLT-02 does not appear to have been released yet.[1]
Clinical data | |
---|---|
Other names | Progesterone conjugate |
Drug class | Progestogen; Neurosteroid |
See also
References
- "Progesterone conjugate - Levolta Pharmaceuticals - AdisInsight". adisinsight.springer.com.
External links
This article is issued from
Wikipedia.
The text is licensed under Creative
Commons - Attribution - Sharealike.
Additional terms may apply for the media files.